LIN.NASDAQLinde PLC

Form 4: Linde PLC Executive VP David P. Strauss Reports Changes in Beneficial Ownership

Sentiment:

SEC Form 4


Executive VP and Chief HR Officer of Linde PLC, David P. Strauss, reports transactions involving ordinary shares and derivative securities, including acquisitions, disposals, and vesting of stock options and restricted stock units.

Summary

  • David P. Strauss, Executive VP and Chief HR Officer of Linde PLC, filed a Form 4 detailing changes in beneficial ownership.
  • On March 7, 2024, Strauss acquired 7,545 ordinary shares at $154.
  • He disposed of 5,022 shares to cover exercise costs and tax withholdings at $466.15.
  • Additionally, he sold 2,522 shares at $465.65 and 1 share at $466.32.
  • Strauss also acquired 1,235 Restricted Stock Units (RSUs) that will vest on or about March 7, 2027.
  • He holds various stock options with exercise prices ranging from $154 to $465.29 and expiration dates between 2028 and 2034.
  • Following these transactions, Strauss directly owns 23,939.147 ordinary shares and indirectly owns 1,909.032 shares through a 401(k).
  • He also holds various derivative securities, including RSUs and stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing of stock transactions. The executive is selling some shares, which could be seen as slightly negative, but also acquiring RSUs, which is positive.

Positives

  • The granting of Restricted Stock Units and stock options to the executive suggests continued alignment of interests with shareholders.
  • The executive maintains a significant holding of Linde PLC shares, indicating confidence in the company's future.

Negatives

  • The sale of shares by the executive, even if to cover taxes, could be perceived negatively by some investors.

Risks

  • Fluctuations in Linde PLC's stock price could impact the value of the executive's holdings and future option exercises.
  • Changes in company performance or strategy could affect the vesting and payout of RSUs and stock options.

Future Outlook

The document does not contain explicit forward-looking statements, but the vesting schedules of RSUs and stock options suggest a long-term incentive structure for the executive.

Industry Context

Executive compensation and stock ownership are common practices in publicly traded companies like Linde PLC to align management's interests with those of shareholders. Form 4 filings are a standard part of regulatory compliance.

Comparison to Industry Standards

  • Executive compensation packages, including stock options and RSUs, are standard practice among large, publicly traded companies such as Linde PLC.
  • Companies like Air Products and Chemicals (APD) and Air Liquide (AI) also utilize similar equity-based compensation to incentivize their executives.
  • The vesting schedules and exercise prices of the options are within typical ranges for executive compensation plans in the industrial gases sector.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders due to the change in the executive's holdings.
  • Employees may be indirectly affected by the executive's compensation structure, which is designed to align with company performance.

Key Dates

DateDescription
03/20/2020Start date for vesting of 20,985 stock options exercisable at $176.63.
03/08/2022Start date for vesting of 15,925 stock options exercisable at $253.68.
03/07/2023Start date for vesting of 10,200 stock options exercisable at $270.99.
03/09/2021Start date for vesting of 20,870 stock options exercisable at $173.13.
02/27/2028Expiration date for 7,545 stock options exercisable at $154.
03/07/2024Date of transactions involving ordinary shares and derivative securities.
03/07/2024Start date for vesting of 8,515 stock options exercisable at $354.14.
03/07/2025Start date for vesting of 8,010 stock options exercisable at $465.29.
03/07/2025Vesting date for 1,180 Restricted Stock Units.
03/07/2026Vesting date for 1,290 Restricted Stock Units.
03/07/2027Vesting date for 1,235 Restricted Stock Units.
03/20/2029Expiration date for 20,985 stock options exercisable at $176.63.
03/09/2030Expiration date for 20,870 stock options exercisable at $173.13.
03/08/2031Expiration date for 15,925 stock options exercisable at $253.68.
03/07/2032Expiration date for 10,200 stock options exercisable at $270.99.
03/07/2033Expiration date for 8,515 stock options exercisable at $354.14.
03/07/2034Expiration date for 8,010 stock options exercisable at $465.29.
03/11/2024Date of signature by attorney-in-fact.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.